Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
This partnership will revolutionize Pharmarack's digital infrastructure with Snowflake's single, integrated platform to facilitate advanced analytic
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Pfizer is likely to show GSK significant competition
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
The drug exhibited greater treatment persistence and control of moderate-to-severe PsO symptoms compared to secukinumab and ixekizumab
Farxiga is expected to have such a strong influence on the market due to the impressive results
Subscribe To Our Newsletter & Stay Updated
